Enstar Group Limited Reports Third Quarter Results
Nov 3, 2022
- Net Loss of
$444 million and Return on Equity of (10.6)%, driven by unrealized losses on fixed income securities in rising interest rate environment - Book Value per Ordinary Share of
$208.60 ($206.25 Adjusted*), as ofSeptember 30, 2022 - Entered into a reinsurance agreement with Argo for ground up reserves of
$746 million and completed agreement withProbitas Managing Agency Limited to cover 2018 and prior year of account exposures of Syndicate 1492 - Completed commutation of Enhanzed Re’s catastrophe book and received regulatory approval to novate Enhanzed Re’s portfolio of deferred annuities and whole life policies, which is expected to close early November
Third Quarter 2022 Highlights:
- Net loss of
$444 million , or$26.10 per diluted ordinary share, compared to$196 million , or$10.68 per diluted ordinary share, for the three months endedSeptember 30, 2021 . - Return on equity ("ROE") of (10.6)% and Adjusted ROE* of (2.9)% for the quarter compared to (2.9)% and (2.8)%, respectively, in the third quarter 2021. ROE was impacted by
$395 million of net unrealized losses arising primarily from interest rate increases on fixed maturity portfolios that are classified as trading, combined with$151 million of net unrealized losses in Enstar's non-core portfolios. - Our Group regulatory solvency, or economic balance sheet, strengthened during the third quarter due to:
- the impact of a higher discount rate on our reserves; and
- our core fixed income securities being shorter in duration than our insurance liabilities.
- Run-off liability earnings ("RLE") of
$109 million , or 3.7% were driven by reductions in the value of certain portfolios that are held at fair value and favorable development on our workers' compensation and marine, aviation and transit lines of business, partially offset by adverse development on our general casualty and motor lines of business. - Entered into loss portfolio transfer (“LPT”) agreement with a wholly-owned subsidiary of Argo Group International Holdings, Ltd. (“Argo”) covering a number of its
U.S. casualty insurance portfolios, including construction, for accident years 2011 to 2019. The LPT agreement covers ground up reserves of $746 million, and an additional $275 million of cover in excess of $821 million, up to a policy limit of$1 .1 billion. Argo will retain a loss corridor of $75 million up to $821 million. The closing of the transaction is subject to customary regulatory approvals and other closing conditions and is expected to be completed by the end of 2022.
* Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure.
“The significant rise in interest rates to combat high inflation continues to drive unrealized bond losses in our investment portfolio. However, we expect our bond portfolio to recover these unrealized losses over time as these bonds will amortize back to par or full principal value as they reach maturity.
Operationally, we are pleased with the accretive transactions signed with Argo and Probitas, as well as our robust pipeline of opportunities. These transactions further demonstrate Enstar’s ability to provide capital relief solutions to partners of varying size and jurisdictions.
Our balance sheet remains strong, and we have the capacity to meet market demand. We will continue to provide tailored solutions to our clients, drive positive claims outcomes and invest for the long term. We are confident that this focus will provide exceptional returns for our stakeholders.”
Nine months ended
- Net loss of
$1.2 billion , or$70.59 per diluted ordinary share, compared to net earnings of$365 million , or$17.53 per diluted ordinary share, for the nine months endedSeptember 30, 2021 . - ROE of (21.8)% and Adjusted ROE* of (7.0)%, compared to 5.9% and 7.7%, respectively, for the nine months ended
September 30, 2021 . ROE was impacted by unrealized losses arising from interest rate increases on fixed maturity portfolios that are classified as trading combined with unrealized losses in Enstar's non-core portfolios. - Annualized RLE of 3.8% and Annualized Adjusted RLE* of 0.5%, compared to 2.5% and 1.4%, respectively, for the nine months ended
September 30, 2021 . RLE benefited from reductions in the value of certain portfolios that are held at fair value, favorable development on our workers’ compensation, professional indemnity/directors and officers and marine, aviation and transit lines of business, and favorable results on Enstar's inactive catastrophe programs held by Enhanzed Re. RLE was impacted by adverse development on our general casualty and motor lines of business. - Annualized total investment return (“TIR”) of (8.7)% and Annualized Adjusted TIR* of (1.0)%, compared to 2.8% and 4.1%, respectively, for the nine months ended
September 30, 2021 . Recognized investment results were impacted by the combination of interest rate increases, widening credit spreads and equity market declines.
* Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure.
Key Financial and Operating Metrics
We use the following GAAP and Non-GAAP measures to monitor the performance of and manage the company:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| $ / pp / bp Change | $ / pp / bp Change | ||||||||||||||||||||||
| (in millions of |
|||||||||||||||||||||||
| Key Earnings Metrics | |||||||||||||||||||||||
| Net (loss) earnings attributable to Enstar ordinary shareholders | $ | (444 | ) | $ | (196 | ) | $ | (248 | ) | $ | (1,219 | ) | $ | 365 | $ | (1,584 | ) | ||||||
| Adjusted operating (loss) income attributable to Enstar ordinary shareholders* | $ | (148 | ) | $ | (174 | ) | $ | 26 | $ | (371 | ) | $ | 417 | $ | (788 | ) | |||||||
| ROE | (10.6 | )% | (2.9 | )% | (7.7 | ) pp | (21.8 | )% | 5.9 | % | (27.7 | )pp | |||||||||||
| Annualized ROE | (29.1 | )% | 7.9 | % | (37.0 | )pp | |||||||||||||||||
| Adjusted ROE* | (2.9 | )% | (2.8 | )% | (0.1 | ) pp | (7.0 | )% | 7.7 | % | (14.7 | )pp | |||||||||||
| Annualized Adjusted ROE* | (9.4 | )% | 10.2 | % | (19.6 | )pp | |||||||||||||||||
| Prior period development | $ | 109 | $ | 69 | $ | 40 | $ | 331 | $ | 189 | $ | 142 | |||||||||||
| Adjusted prior period development* | $ | 14 | $ | 53 | $ | (39 | ) | $ | 42 | $ | 103 | $ | (61 | ) | |||||||||
| Annualized RLE | 3.8 | % | 2.5 | % | 1.3 | pp | |||||||||||||||||
| Annualized Adjusted RLE* | 0.5 | % | 1.4 | % | (0.9 | )pp | |||||||||||||||||
| Key Investment Return Metrics | |||||||||||||||||||||||
| Total investable assets | $ | 19,310 | $ | 21,855 | $ | (2,545 | ) | ||||||||||||||||
| Adjusted total investable assets* | $ | 21,238 | $ | 21,529 | $ | (291 | ) | ||||||||||||||||
| Annualized investment book yield | 2.32 | % | 1.73 | % | 59 | bp | 2.15 | % | 1.91 | % | 24 | bp | |||||||||||
| Annualized TIR | (8.7 | )% | 2.8 | % | (11.5 | )pp | |||||||||||||||||
| Annualized Adjusted TIR* | (1.0 | )% | 4.1 | % | (5.1 | )pp | |||||||||||||||||
| As of | |||||||||||||||||||||||
| Key Shareholder Metrics | |||||||||||||||||||||||
| Book value per ordinary share | $ | 208.60 | $ | 316.34 | $ | (107.74 | ) | ||||||||||||||||
| Adjusted book value per ordinary share* | $ | 206.25 | $ | 310.80 | $ | (104.55 | ) | ||||||||||||||||
pp - Percentage point(s)
bp - Basis point(s)
*Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure.
Results of Operations by Segment - For the Three and Nine Months Ended
Run-off Segment
The following is a discussion and analysis of the results of operations for our Run-off segment.
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| 2022 | 2021 | $ Change | 2022 | 2021 | $ Change | ||||||||||||||||||
| INCOME | (in millions of |
||||||||||||||||||||||
| Net premiums earned | $ | 1 | $ | 39 | $ | (38 | ) | $ | 27 | $ | 154 | $ | (127 | ) | |||||||||
| Other income: | |||||||||||||||||||||||
| Reduction in estimates of net ultimate defendant A&E liabilities - prior periods | — | 5 | (5 | ) | 4 | 19 | (15 | ) | |||||||||||||||
| Reduction in estimated future defendant A&E expenses | — | 1 | (1 | ) | 1 | 4 | (3 | ) | |||||||||||||||
| All other income | 2 | 6 | (4 | ) | 14 | 25 | (11 | ) | |||||||||||||||
| Total other income | 2 | 12 | (10 | ) | 19 | 48 | (29 | ) | |||||||||||||||
| Total income | 3 | 51 | (48 | ) | 46 | 202 | (156 | ) | |||||||||||||||
| EXPENSES | |||||||||||||||||||||||
| Net incurred losses and LAE: | |||||||||||||||||||||||
| Current period | 10 | 35 | (25 | ) | 35 | 121 | (86 | ) | |||||||||||||||
| Prior periods: | |||||||||||||||||||||||
| Reduction in estimates of net ultimate losses | (46 | ) | (72 | ) | 26 | (183 | ) | (139 | ) | (44 | ) | ||||||||||||
| Reduction in provisions for ULAE | (15 | ) | (14 | ) | (1 | ) | (49 | ) | (45 | ) | (4 | ) | |||||||||||
| Total prior periods | (61 | ) | (86 | ) | 25 | (232 | ) | (184 | ) | (48 | ) | ||||||||||||
| Total net incurred losses and LAE | (51 | ) | (51 | ) | — | (197 | ) | (63 | ) | (134 | ) | ||||||||||||
| Acquisition costs | 1 | 8 | (7 | ) | 18 | 37 | (19 | ) | |||||||||||||||
| General and administrative expenses | 34 | 47 | (13 | ) | 109 | 139 | (30 | ) | |||||||||||||||
| Total expenses | (16 | ) | 4 | (20 | ) | (70 | ) | 113 | (183 | ) | |||||||||||||
| SEGMENT NET EARNINGS | $ | 19 | $ | 47 | $ | (28 | ) | $ | 116 | $ | 89 | $ | 27 | ||||||||||
Three Months Ended
- A
$25 million decrease in favorable PPD, driven by a$26 million decrease in the reduction in estimates of net ultimate losses.- Results for the three months ended
September 30, 2022 were driven by $54 million of favorable development on our workers’ compensation line of business as a result of favorable claim settlements, most notably in the 2018 and 2019 acquisition years, and $28 million of favorable development on our marine, aviation and transit line of business as a result of lower claim activity, relating to the 2014, 2018 and 2019 acquisition years; partially offset by - Adverse development in the 2018, 2020 and 2021 acquisition years on our general casualty and motor lines of business of $21 million and $19 million, respectively, primarily due to worse than expected claims experience and adverse development on claims.
- Results for the three months ended
September 30, 2021 were primarily driven by favorable development on our workers’ compensation, property, construction defect and marine, aviation and transit lines as a result of better than expected claims experience and favorable results from actuarial reviews.
- Results for the three months ended
- A reduction in other income of
$10 million , primarily driven by lower favorable prior period development related to our defendant A&E liabilities in comparison to the prior period; and - Reductions in net premiums earned that were greater than the reductions in current period net incurred losses and LAE and acquisition costs, following our exit of our
StarStone International business beginning in 2020; partially offset by - A decrease in general and administrative expenses of
$13 million , primarily driven by a continued decrease in salaries and benefits and other costs following our exit of our StarStone business beginning in 2020 and a reduction in IT costs as a result of reduced project activity.
Nine Months Ended
- A
$48 million increase in favorable PPD, driven by a$44 million increase in the reduction in estimates of net ultimate losses.- Results for the nine months ended
September 30, 2022 were driven by favorable development of $104 million on our workers’ compensation line of business as a result of favorable claim settlements, most notably in the 2018 and 2021 acquisition years. We also had favorable development of $85 million on our professional indemnity/directors and officers line of business relating to the 2018 and 2021 acquisition years and favorable development of $38 million on our marine, aviation and transit lines of business relating to the 2014, 2018 and 2019 acquisition years as a result of lower claims activity; partially offset by - Adverse development on our general casualty and motor lines of business of $31 million and $20 million, respectively, most notably impacting the 2018, 2020 and 2021 acquisition years, as a result of worse than expected claims experience and adverse development on claims.
- Results for the nine months ended
September 30, 2021 were primarily related to favorable development on our workers’ compensation, property and marine, aviation and transit lines of business as a result of better than expected claims experience and favorable results from actuarial reviews.
- Results for the nine months ended
- A decrease in general and administrative expenses of
$30 million , primarily driven by a continued decrease in salaries and benefits and other costs following our exit of our StarStone business beginning in 2020 and a reduction in IT costs as a result of reduced project activity; partially offset by - A reduction in other income of
$29 million , primarily driven by lower favorable prior period development related to our defendant A&E liabilities; and - Reductions in net premiums earned that were greater than the reductions in current period net incurred losses and LAE and acquisition costs, following our exit of our
StarStone International business beginning in 2020.
Investments Segment
The following is a discussion and analysis of the results of operations for our Investments segment.
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| 2022 | 2021 | $ Change | 2022 | 2021 | $ Change | ||||||||||||||||||
| INCOME | (in millions of |
||||||||||||||||||||||
| Net investment income: | |||||||||||||||||||||||
| Fixed income securities | $ | 94 | $ | 70 | $ | 24 | $ | 247 | $ | 208 | $ | 39 | |||||||||||
| Cash and restricted cash | 2 | (1 | ) | 3 | 3 | (1 | ) | 4 | |||||||||||||||
| Other investments, including equities | 22 | 12 | 10 | 63 | 41 | 22 | |||||||||||||||||
| Less: Investment expenses | (4 | ) | 11 | (15 | ) | (19 | ) | (19 | ) | — | |||||||||||||
| Total net investment income | 114 | 92 | 22 | 294 | 229 | 65 | |||||||||||||||||
| Net realized (losses) gains: | |||||||||||||||||||||||
| Fixed income securities | (23 | ) | 5 | (28 | ) | (88 | ) | (1 | ) | (87 | ) | ||||||||||||
| Other investments, including equities | (13 | ) | — | (13 | ) | (23 | ) | 2 | (25 | ) | |||||||||||||
| Net realized (losses) gains: | (36 | ) | 5 | (41 | ) | (111 | ) | 1 | (112 | ) | |||||||||||||
| Net unrealized (losses) gains: | |||||||||||||||||||||||
| Fixed income securities | (391 | ) | (91 | ) | (300 | ) | (1,061 | ) | (180 | ) | (881 | ) | |||||||||||
| Other investments, including equities | (151 | ) | (187 | ) | 36 | (445 | ) | 292 | (737 | ) | |||||||||||||
| Total net unrealized (losses) gains: | (542 | ) | (278 | ) | (264 | ) | (1,506 | ) | 112 | (1,618 | ) | ||||||||||||
| Total income | (464 | ) | (181 | ) | (283 | ) | (1,323 | ) | 342 | (1,665 | ) | ||||||||||||
| EXPENSES | |||||||||||||||||||||||
| General and administrative expenses | 9 | 8 | 1 | 28 | 24 | 4 | |||||||||||||||||
| Total expenses | 9 | 8 | 1 | 28 | 24 | 4 | |||||||||||||||||
| Earnings (losses) from equity method investments | (20 | ) | (14 | ) | (6 | ) | 12 | 101 | (89 | ) | |||||||||||||
| SEGMENT NET (LOSS) EARNINGS | $ | (493 | ) | $ | (203 | ) | $ | (290 | ) | $ | (1,339 | ) | $ | 419 | $ | (1,758 | ) | ||||||
Three and Nine Months Ended
- An increase in net realized and unrealized losses on our fixed income securities of
$328 million and$968 million , respectively, driven by rising interest rates and widening credit spreads; - Net realized and unrealized losses on our other investments, including equities, of
$164 million and$468 million , respectively, in comparison to net losses of$187 million and net gains of$294 million , respectively, in the comparative periods, primarily driven by negative performance from our public equities, CLO equities and hedge funds as a result of significant volatility in global equity markets and widening high yield credit spreads; and - An
$89 million decrease in earnings from equity method investments for the nine months endedSeptember 30, 2022 , largely due to our acquisition of the controlling interest in Enhanzed Re, effectiveSeptember 1, 2021 (consolidated net loss from Enhanzed Re was $231 million for the nine months endedSeptember 30, 2022 ). Prior to that date, the results of Enhanzed Re were recorded in earnings from equity method investments within the Investments segment; partially offset by: - Increases in our net investment income of
$22 million and$65 million , respectively, which is primarily due to an increase in our average aggregate fixed income assets due to new business during the past year, in addition to the investment of new premium and reinvestment of fixed maturities at higher yields and the impact of rising interest rates on the$2 .7 billion of our fixed maturity investments that are subject to floating interest rates. Our floating rate investments generated increased net investment income of $16 million and $39 million, respectively, which equates to an increase of 257 and 165 basis points, respectively, on those investments in comparison to the prior period.
Total investment losses on the fixed income securities that support our Enhanzed Re life reinsurance business for the three and nine months ended
Income and Earnings by Segment - For the Three and Nine Months Ended
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
2022 |
2021 |
$ Change | 2022 |
2021 |
$ Change | ||||||||||||||||||
| (in millions of |
|||||||||||||||||||||||
| INCOME | |||||||||||||||||||||||
| Run-off | $ | 3 | $ | 51 | $ | (48 | ) | $ | 46 | $ | 202 | $ | (156 | ) | |||||||||
| Assumed Life | 2 | — | 2 | 17 | — | 17 | |||||||||||||||||
| Investments | (464 | ) | (181 | ) | (283 | ) | (1,323 | ) | 342 | (1,665 | ) | ||||||||||||
| Legacy Underwriting | — | 11 | (11 | ) | 8 | 39 | (31 | ) | |||||||||||||||
| Subtotal | (459 | ) | (119 | ) | (340 | ) | (1,252 | ) | 583 | (1,835 | ) | ||||||||||||
| Corporate and other | (7 | ) | 48 | (55 | ) | 10 | 52 | (42 | ) | ||||||||||||||
| Total income | $ | (466 | ) | $ | (71 | ) | $ | (395 | ) | $ | (1,242 | ) | $ | 635 | $ | (1,877 | ) | ||||||
| SEGMENT NET (LOSS) EARNINGS | |||||||||||||||||||||||
| Run-off | $ | 19 | $ | 47 | $ | (28 | ) | $ | 116 | $ | 89 | $ | 27 | ||||||||||
| Assumed Life | (7 | ) | — | (7 | ) | 15 | — | 15 | |||||||||||||||
| Investments | (493 | ) | (203 | ) | (290 | ) | (1,339 | ) | 419 | (1,758 | ) | ||||||||||||
| Legacy Underwriting | — | — | — | — | — | — | |||||||||||||||||
| Total segment net (loss) earnings | (481 | ) | (156 | ) | (325 | ) | (1,208 | ) | 508 | (1,716 | ) | ||||||||||||
| Corporate and other(1)(2) | 37 | (40 | ) | 77 | (11 | ) | (143 | ) | 132 | ||||||||||||||
| NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS | $ | (444 | ) | $ | (196 | ) | $ | (248 | ) | $ | (1,219 | ) | $ | 365 | $ | (1,584 | ) | ||||||
(1) Other income (expense) for corporate and other activities includes the amortization of fair value adjustments associated with the acquisition of
(2) Net incurred losses and LAE for corporate and other activities includes the amortization of deferred charge assets (“DCAs”) on retroactive reinsurance contracts, fair value adjustments associated with the acquisition of companies and the changes in the discount rate and risk margin components of the fair value of assets and liabilities related to our assumed retroactive reinsurance contracts for which we have elected the fair value option. The three and nine months ended
For additional detail on the Assumed Life segment, the Legacy Underwriting segment and Corporate and other activities, please refer to the Form 10-Q.
Cautionary Statement
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the intent, belief or current expectations of Enstar and its management team. Investors are cautioned that any such forward-looking statements speak only as of the date they are made, are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Important risk factors regarding Enstar can be found under the heading "Risk Factors" in our Form 10-K for the year ended
About Enstar
Enstar is a NASDAQ-listed leading global (re)insurance group that offers capital release solutions through its network of group companies in
Contacts
For Investors:
For Media:
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)
For the Three and Nine Months Ended
| Three Months Ended |
Nine Months Ended |
||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||
| (expressed in millions of |
|||||||||||||||
| INCOME | |||||||||||||||
| Net premiums earned | $ | 4 | $ | 52 | $ | 52 | $ | 204 | |||||||
| Net investment income | 116 | 93 | 302 | 231 | |||||||||||
| Net realized (losses) gains | (36 | ) | 6 | (111 | ) | 1 | |||||||||
| Net unrealized (losses) gains | (546 | ) | (280 | ) | (1,518 | ) | 110 | ||||||||
| Other (expense) income | (4 | ) | 11 | 33 | 27 | ||||||||||
| Net gain on purchase and sales of subsidiaries | — | 47 | — | 62 | |||||||||||
| Total income | (466 | ) | (71 | ) | (1,242 | ) | 635 | ||||||||
| EXPENSES | |||||||||||||||
| Net incurred losses and loss adjustment expenses | |||||||||||||||
| Current period | 13 | 42 | 39 | 146 | |||||||||||
| Prior periods | (109 | ) | (69 | ) | (331 | ) | (189 | ) | |||||||
| Total net incurred losses and loss adjustment expenses | (96 | ) | (27 | ) | (292 | ) | (43 | ) | |||||||
| Policyholder benefit expenses | 7 | — | 25 | — | |||||||||||
| Acquisition costs | — | 11 | 20 | 50 | |||||||||||
| General and administrative expenses | 67 | 93 | 235 | 269 | |||||||||||
| Interest expense | 23 | 18 | 71 | 51 | |||||||||||
| Net foreign exchange gains | (17 | ) | (2 | ) | (27 | ) | (9 | ) | |||||||
| Total expenses | (16 | ) | 93 | 32 | 318 | ||||||||||
| (LOSS) EARNINGS BEFORE INCOME TAXES | (450 | ) | (164 | ) | (1,274 | ) | 317 | ||||||||
| Income tax expense | (8 | ) | (10 | ) | (4 | ) | (13 | ) | |||||||
| (Losses) earnings from equity method investments | (20 | ) | (14 | ) | 12 | 101 | |||||||||
| NET (LOSS) EARNINGS | (478 | ) | (188 | ) | (1,266 | ) | 405 | ||||||||
| Net loss (earnings) attributable to noncontrolling interests | 43 | 1 | 74 | (13 | ) | ||||||||||
| NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR | (435 | ) | (187 | ) | (1,192 | ) | 392 | ||||||||
| Dividends on preferred shares | (9 | ) | (9 | ) | (27 | ) | (27 | ) | |||||||
| NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS | $ | (444 | ) | $ | (196 | ) | $ | (1,219 | ) | $ | 365 | ||||
| (Loss) earnings per ordinary share attributable to Enstar: | |||||||||||||||
| Basic | $ | (26.10 | ) | $ | (10.68 | ) | $ | (70.59 | ) | $ | 17.78 | ||||
| Diluted | $ | (26.10 | ) | $ | (10.68 | ) | $ | (70.59 | ) | $ | 17.53 | ||||
| Weighted average ordinary shares outstanding: | |||||||||||||||
| Basic | 17,013,348 | 18,349,483 | 17,269,870 | 20,502,755 | |||||||||||
| Diluted | 17,126,880 | 18,548,368 | 17,382,578 | 20,793,640 | |||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
As of
| (in millions of U.S. dollars, except share data) | |||||||
| ASSETS | |||||||
| Short-term investments, trading, at fair value | $ | 14 | $ | 6 | |||
| Short-term investments, available-for-sale, at fair value (amortized cost: 2022 — |
9 | 34 | |||||
| Fixed maturities, trading, at fair value | 2,315 | 3,756 | |||||
| Fixed maturities, available-for-sale, at fair value (amortized cost: 2022 — |
4,868 | 5,652 | |||||
| Funds held - directly managed | 2,150 | 3,007 | |||||
| Equities, at fair value (cost: 2022 — |
1,199 | 1,995 | |||||
| Other investments, at fair value | 3,203 | 2,333 | |||||
| Equity method investments | 468 | 493 | |||||
| Total investments | 14,226 | 17,276 | |||||
| Cash and cash equivalents | 923 | 1,646 | |||||
| Restricted cash and cash equivalents | 434 | 446 | |||||
| Reinsurance balances recoverable on paid and unpaid losses (net of allowance: 2022 — |
886 | 1,085 | |||||
| Reinsurance balances recoverable on paid and unpaid losses, at fair value | 287 | 432 | |||||
| Insurance balances recoverable (net of allowance: 2022 and 2021 — |
190 | 213 | |||||
| Funds held by reinsured companies | 3,727 | 2,340 | |||||
| Deferred charge assets | 255 | 371 | |||||
| Other assets | 624 | 620 | |||||
| TOTAL ASSETS | $ | 21,552 | $ | 24,429 | |||
| LIABILITIES | |||||||
| Losses and loss adjustment expenses | $ | 11,549 | $ | 11,269 | |||
| Losses and loss adjustment expenses, at fair value | 1,286 | 1,989 | |||||
| Future policyholder benefits | 1,285 | 1,502 | |||||
| Defendant asbestos and environmental liabilities | 617 | 638 | |||||
| Insurance and reinsurance balances payable | 154 | 254 | |||||
| Debt obligations | 1,905 | 1,691 | |||||
| Other liabilities | 432 | 581 | |||||
| TOTAL LIABILITIES | 17,228 | 17,924 | |||||
| COMMITMENTS AND CONTINGENCIES | |||||||
| REDEEMABLE NONCONTROLLING INTERESTS | 166 | 179 | |||||
| SHAREHOLDERS’ EQUITY | |||||||
| Ordinary Shares (par value |
|||||||
| Voting Ordinary Shares (issued and outstanding 2022: 15,986,489; 2021: 16,625,862) | 16 | 17 | |||||
| Non-voting convertible ordinary Series C Shares (issued and outstanding 2022 and 2021: 1,192,941) | 1 | 1 | |||||
| Non-voting convertible ordinary Series E Shares (issued and outstanding 2022 and 2021: 404,771) | — | — | |||||
| Preferred Shares: | |||||||
| Series C Preferred Shares (issued and held in treasury 2022 and 2021: 388,571) | — | — | |||||
| Series D Preferred Shares (issued and outstanding 2022 and 2021: 16,000; liquidation preference |
400 | 400 | |||||
| Series E Preferred Shares (issued and outstanding 2022 and 2021: 4,400; liquidation preference |
110 | 110 | |||||
| (422 | ) | (422 | ) | ||||
| Joint Share Ownership Plan (voting ordinary shares, held in trust 2022 and 2021: 565,630) | (1 | ) | (1 | ) | |||
| Additional paid-in capital | 757 | 922 | |||||
| Accumulated other comprehensive loss | (667 | ) | (16 | ) | |||
| Retained earnings | 3,866 | 5,085 | |||||
| Total Enstar Shareholders’ Equity | 4,060 | 6,096 | |||||
| Noncontrolling interests | 98 | 230 | |||||
| TOTAL SHAREHOLDERS’ EQUITY | 4,158 | 6,326 | |||||
| TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND SHAREHOLDERS’ EQUITY | $ | 21,552 | $ | 24,429 | |||
Non-GAAP Financial Measures
In addition to our key financial measures presented in accordance with GAAP, we present other non-GAAP financial measures that we use to manage our business, compare our performance against prior periods and against our peers, and as performance measures in our incentive compensation program.
These non-GAAP financial measures provide an additional view of our operational performance over the long-term and provide the opportunity to analyze our results in a way that is more aligned with the manner in which our management measures our underlying performance.
The presentation of these non-GAAP financial measures, which may be defined and calculated differently by other companies, is used to enhance the understanding of certain aspects of our financial performance. It is not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.
Some of the adjustments reflected in our non-GAAP measures are recurring items, such as the exclusion of adjustments to net realized and unrealized (gains)/losses on fixed maturity investments recognized in our income statement, the fair value of certain of our loss reserve liabilities for which we have elected the fair value option, and the amortization of fair value adjustments.
Management makes these adjustments in assessing our performance so that the changes in fair value due to interest rate movements, which are applied to some but not all of our assets and liabilities as a result of preexisting accounting elections, do not impair comparability across reporting periods.
It is important for the readers of our periodic filings to understand that these items will recur from period to period.
However, we exclude these items for the purpose of presenting a comparable view across reporting periods of the impact of our underlying claims management and investment without the effect of interest rate fluctuations on assets that we anticipate to hold to maturity and non-cash changes to the fair value of our reserves.
Similarly, our non-GAAP measures reflect the exclusion of certain items that we deem to be nonrecurring, unusual or infrequent when the nature of the charge or gain is such that it is not reasonably likely that such item may recur within two years, nor was there a similar charge or gain in the preceding two years. This includes adjustments related to bargain purchase gains on acquisitions of businesses, net gains or losses on sales of subsidiaries, net assets of held for sale or disposed subsidiaries classified as discontinued operations and other items that we separately disclose.
We have presented the results and GAAP reconciliations for these measures further below. The following tables present more information on each non-GAAP measure.
| Non-GAAP Measure | Definition | Purpose of Non-GAAP Measure over GAAP Measure | ||
| Adjusted book value per ordinary share | Total Enstar ordinary shareholders' equity Divided by Number of ordinary shares outstanding, adjusted for: -the ultimate effect of any dilutive securities on the number of ordinary shares outstanding |
Increases the number of ordinary shares to reflect the exercise of equity awards granted but not yet vested as, over the long term, this presents both management and investors with a more economically accurate measure of the realizable value of shareholder returns by factoring in the impact of share dilution. We use this non-GAAP measure in our incentive compensation program. |
||
| Adjusted return on equity (%) | Adjusted operating income (loss) attributable to Enstar ordinary shareholders divided by adjusted opening Enstar ordinary shareholder's equity | Calculating the operating income (loss) as a percentage of our adjusted opening Enstar ordinary shareholders' equity provides a more consistent measure of the performance of our business by enabling comparison between the financial periods presented. We eliminate the impact of net realized and unrealized (gains) losses on fixed maturity investments and funds-held directly managed and the change in fair value of insurance contracts for which we have elected the fair value option, as:
We include the amortization of fair value adjustments as a non-GAAP adjustment to the adjusted operating income (loss) attributable to Enstar ordinary shareholders as it is a non-cash charge that is not reflective of the impact of our claims management strategies on our loss portfolios. We eliminate the net gain (loss) on the purchase and sales of subsidiaries and net earnings from discontinued operations, as these items are not indicative of our ongoing operations. We use this non-GAAP measure in our incentive compensation program. |
||
| Adjusted operating income (loss) attributable to Enstar ordinary shareholders (numerator) |
Net earnings (loss) attributable to Enstar ordinary shareholders, adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed -change in fair value of insurance contracts for which we have elected the fair value option(1) -amortization of fair value adjustments -net gain/loss on purchase and sales of subsidiaries (if any) -net earnings from discontinued operations (if any) -tax effects of adjustments -adjustments attributable to noncontrolling interests |
|||
| Adjusted opening Enstar ordinary shareholders' equity (denominator) | Opening Enstar ordinary shareholders' equity, less: -net unrealized gains (losses) on fixed maturity investments and funds held-directly managed, -fair value of insurance contracts for which we have elected the fair value option(1), -fair value adjustments, and -net assets of held for sale or disposed subsidiaries classified as discontinued operations (if any) |
|||
| Adjusted total investment return (%) | Adjusted total investment return (dollars) recognized in earnings for the applicable period divided by period average adjusted total investable assets. | Provides a key measure of the return generated on the capital held in the business and is reflective of our investment strategy. Provides a consistent measure of investment returns as a percentage of all assets generating investment returns. We adjust our investment returns to eliminate the impact of the change in fair value of fixed maturity securities (both credit spreads and interest rates), as we typically hold most of these investments until the earlier of maturity or used to fund any settlement of related liabilities which are generally recorded at cost. |
||
| Adjusted total investment return ($) (numerator) | Total investment return (dollars), adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed |
|||
| Adjusted average aggregate total investable assets (denominator) | Total average investable assets, adjusted for: -net unrealized (gains) losses on fixed maturities, AFS investments included within AOCI -net unrealized (gains) losses on fixed maturities, trading instruments |
|||
| Adjusted run-off liability earnings (%) | Adjusted PPD divided by average adjusted net loss reserves |
Calculating the RLE as a percentage of our adjusted average net loss reserves provides a more meaningful and comparable measurement of the impact of our claims management strategies on our loss portfolios across acquisition years and also to our overall financial periods. We use this measure to evaluate the impact of our claims management strategies because it provides visibility into our ability to settle our claims obligations for amounts less than our initial estimate at the point of acquiring the obligations. In order to provide a complete and consistent picture of our claims management performance, we combine:
We also include our performance in managing claims on our defendant A&E liabilities, that do not form part of loss reserves. The remaining components of periodic recurring net incurred losses and LAE and net loss reserves are not considered key components of our claims management performance for the following reasons:
|
||
| Adjusted prior period development (numerator) |
Prior period net incurred losses and LAE, adjusted to: Remove: -Legacy Underwriting and Assumed Life operations -the reduction/(increase) in provisions for unallocated LAE (ULAE) -amortization of fair value adjustments, -change in fair value of insurance contracts for which we have elected the fair value option (1), and Add: -the reduction/(increase) in estimates of our defendant A&E ultimate net liabilities. |
|||
| Adjusted net loss reserves (denominator) |
Net losses and LAE, adjusted to: Remove: -Legacy Underwriting and Assumed Life net loss reserves -current period net loss reserves -the net ULAE provision -net fair value adjustments associated with the acquisition of companies, -the fair value adjustments for contracts for which we have elected the fair value option (1) and Add: -net nominal defendant asbestos and environmental exposures. |
(1) Comprises the discount rate and risk margin components.
(2) As described in Note 5 to our consolidated financial statements in our Annual Report on Form 10-K for the year ended
Reconciliation of GAAP to Non-GAAP Measures
The table below presents a reconciliation of BVPS to Adjusted BVPS*:
| Equity(1) | Ordinary Shares | Per Share Amount | Equity(1) | Ordinary Shares | Per Share Amount | |||||||||||
| (in millions of |
||||||||||||||||
| Book value per ordinary share | $ | 3,550 | 17,018,571 | $ | 208.60 | $ | 5,586 | 17,657,944 | $ | 316.34 | ||||||
| Non-GAAP adjustments: | ||||||||||||||||
| Share-based compensation plans | 193,951 | 315,205 | ||||||||||||||
| Adjusted book value per ordinary share* | $ | 3,550 | 17,212,522 | $ | 206.25 | $ | 5,586 | 17,973,149 | $ | 310.80 | ||||||
(1) Equity comprises Enstar ordinary shareholders' equity, which is calculated as Enstar shareholders' equity less preferred shares (
The tables below present a reconciliation of Annualized ROE to Annualized Adjusted ROE*:
| Three Months Ended | |||||||||||||||||||||||
| Net (loss) earnings(1) | Opening equity(1) | (Adj) ROE | Annualized (Adj) ROE |
Net (loss) earnings(1) | Opening equity(1) | (Adj) ROE | Annualized (Adj) ROE | ||||||||||||||||
| (in millions of |
|||||||||||||||||||||||
| Net (loss) earnings/Opening equity/ROE/Annualized ROE(1) | $ | (444 | ) | $ | 4,183 | (10.6)% | (42.5) % | $ | (196 | ) | $ | 6,677 | (2.9) % | (11.7) % | |||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||
| Remove: | |||||||||||||||||||||||
| Net realized and unrealized losses (gains) on fixed maturity investments and funds held - directly managed / Net unrealized losses (gains) on fixed maturity investments and funds held - directly managed(2) | 418 | 1,245 | 87 | (339 | ) | ||||||||||||||||||
| Change in fair value of insurance contracts for which we have elected the fair value option / Fair value of insurance contracts for which we have elected the fair value option(3) | (82 | ) | (239 | ) | (10 | ) | (91 | ) | |||||||||||||||
| Amortization of fair value adjustments / Fair value adjustments | 4 | (99 | ) | 5 | (120 | ) | |||||||||||||||||
| Net gain on purchase and sales of subsidiaries | — | — | (47 | ) | — | ||||||||||||||||||
| Tax effects of adjustments(4) | (2 | ) | — | (5 | ) | — | |||||||||||||||||
| Adjustments attributable to noncontrolling interests(5) | (42 | ) | — | (8 | ) | — | |||||||||||||||||
| Adjusted operating (loss) income/Adjusted opening equity/Adjusted ROE/Annualized adjusted ROE* | $ | (148 | ) | $ | 5,090 | (2.9)% | (11.6) % | $ | (174 | ) | $ | 6,127 | (2.8) % | (11.4) % | |||||||||
(1) Net (loss) earnings comprises net (loss) earnings attributable to Enstar ordinary shareholders, prior to any non-GAAP adjustments. Opening equity comprises Enstar ordinary shareholders' equity, which is calculated as opening Enstar shareholders' equity less preferred shares (
(2) Represents the net realized and unrealized losses (gains) related to fixed maturity securities. Our fixed maturity securities are held directly on our balance sheet and also within the "Funds held - directly managed" balance.
(3) Comprises the discount rate and risk margin components.
(4) Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated at the applicable jurisdictional tax rate.
(5) Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interests associated with the specific subsidiaries to which the adjustments relate.
*Non-GAAP measure.
| Nine Months Ended | |||||||||||||||||||||||||
| Net (loss) earnings(1) | Opening equity(1) | (Adj) ROE | Annualized (Adj) ROE |
Net (loss) earnings(1) | Opening equity(1) | (Adj) ROE | Annualized (Adj) ROE | ||||||||||||||||||
| (in millions of |
|||||||||||||||||||||||||
| Net (loss) earnings/Opening equity/ROE/Annualized ROE(1) | $ | (1,219 | ) | $ | 5,586 | (21.8)% | (29.1)% | $ | 365 | $ | 6,164 | 5.9 | % | 7.9 | % | ||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||||
| Net realized and unrealized losses on fixed maturity investments and funds held - directly managed / Net unrealized gains on fixed maturity investments and funds held - directly managed(2) | 1,161 | (89 | ) | 183 | (560 | ) | |||||||||||||||||||
| Change in fair value of insurance contracts for which we have elected the fair value option / Fair value of insurance contracts for which we have elected the fair value option(3) | (228 | ) | (107 | ) | (68 | ) | (33 | ) | |||||||||||||||||
| Amortization of fair value adjustments / Fair value adjustments | 11 | (106 | ) | 13 | (128 | ) | |||||||||||||||||||
| Net gain on purchase and sales of subsidiaries | — | — | (62 | ) | — | ||||||||||||||||||||
| Tax effects of adjustments(4) | (6 | ) | — | (18 | ) | — | |||||||||||||||||||
| Adjustments attributable to noncontrolling interests(5) | (90 | ) | — | 4 | — | ||||||||||||||||||||
| Adjusted operating (loss) income/Adjusted opening equity/Adjusted ROE/Annualized adjusted ROE* | $ | (371 | ) | $ | 5,284 | (7.0)% | (9.4)% | $ | 417 | $ | 5,443 | 7.7 | % | 10.2 | % | ||||||||||
(1) Net (loss) earnings comprises net (loss) earnings attributable to Enstar ordinary shareholders, prior to any non-GAAP adjustments. Opening equity comprises Enstar ordinary shareholders' equity, which is calculated as opening Enstar shareholders' equity less preferred shares (
(2) Represents the net realized and unrealized losses (gains) related to fixed maturity securities. Our fixed maturity securities are held directly on our balance sheet and also within the "Funds held - directly managed" balance.
(3) Comprises the discount rate and risk margin components.
(4) Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated at the applicable jurisdictional tax rate.
(5) Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interests associated with the specific subsidiaries to which the adjustments relate.
*Non-GAAP measure.
The tables below present a reconciliation of PPD to Adjusted PPD* and Annualized RLE to Annualized Adjusted RLE*:
| Three Months Ended | As of | Three Months Ended | |||||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
| (in millions of |
|||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 109 | $ | 11,564 | $ | 12,238 | $ | 11,901 | 3.7 | % | |||||||||
| Non-GAAP Adjustments: | |||||||||||||||||||
| Assumed Life | — | (139 | ) | (147 | ) | (143 | ) | ||||||||||||
| Legacy Underwriting | (2 | ) | (136 | ) | (140 | ) | (138 | ) | |||||||||||
| Net loss reserves - current period | — | (36 | ) | (26 | ) | (31 | ) | ||||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (15 | ) | (480 | ) | (504 | ) | (492 | ) | |||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 4 | 95 | 99 | 97 | |||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option(1) | (82 | ) | 305 | 239 | 272 | ||||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | — | 571 | 574 | 573 | |||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 14 | $ | 11,744 | $ | 12,333 | $ | 12,039 | 0.5 | % | |||||||||
| Three Months Ended | As of | Three Months Ended | |||||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
| (in millions of |
|||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 69 | $ | 11,963 | $ | 10,835 | $ | 11,399 | 2.4 | % | |||||||||
| Non-GAAP Adjustments: | |||||||||||||||||||
| Assumed Life | — | (177 | ) | — | (89 | ) | |||||||||||||
| Legacy Underwriting | (2 | ) | (147 | ) | (156 | ) | (152 | ) | |||||||||||
| Net loss reserves - current period | — | (130 | ) | (91 | ) | (111 | ) | ||||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (14 | ) | (432 | ) | (410 | ) | (421 | ) | |||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 5 | 109 | 120 | 115 | |||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option(1) | (10 | ) | 100 | 91 | 96 | ||||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 5 | 601 | 584 | 593 | |||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 53 | $ | 11,887 | $ | 10,973 | $ | 11,430 | 1.9 | % | |||||||||
(1) Comprises the discount rate and risk margin components.
*Non-GAAP measure.
| Nine Months Ended | As of | Nine Months Ended | |||||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
| (in millions of |
|||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 331 | $ | 11,564 | $ | 11,555 | $ | 11,560 | 3.8 | % | |||||||||
| Non-GAAP Adjustments: | |||||||||||||||||||
| Assumed Life | (29 | ) | (139 | ) | (181 | ) | (160 | ) | |||||||||||
| Legacy Underwriting | 3 | (136 | ) | (153 | ) | (145 | ) | ||||||||||||
| Net loss reserves - current period | — | (36 | ) | — | (18 | ) | |||||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (50 | ) | (480 | ) | (416 | ) | (448 | ) | |||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 11 | 95 | 106 | 101 | |||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option(1) | (228 | ) | 305 | 107 | 206 | ||||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 4 | 571 | 574 | 572 | |||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 42 | $ | 11,744 | $ | 11,592 | $ | 11,668 | 0.5 | % | |||||||||
| Nine Months Ended | As of | Nine Months Ended | |||||||||||||||||
| PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
| (in millions of |
|||||||||||||||||||
| PPD/net loss reserves/Annualized RLE | $ | 189 | $ | 11,963 | $ | 8,544 | $ | 10,254 | 2.5 | % | |||||||||
| Non-GAAP Adjustments: | |||||||||||||||||||
| Assumed Life | — | (177 | ) | — | (89 | ) | |||||||||||||
| Legacy Underwriting | (4 | ) | (147 | ) | (955 | ) | (552 | ) | |||||||||||
| Net loss reserves - current period | — | (130 | ) | — | (65 | ) | |||||||||||||
| Reduction in provisions for ULAE / Net ULAE provisions | (46 | ) | (432 | ) | (334 | ) | (383 | ) | |||||||||||
| Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 13 | 109 | 128 | 119 | |||||||||||||||
| Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option(1) | (68 | ) | 100 | 33 | 67 | ||||||||||||||
| Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 19 | 601 | 615 | 608 | |||||||||||||||
| Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 103 | $ | 11,887 | $ | 8,031 | $ | 9,959 | 1.4 | % | |||||||||
(1) Comprises the discount rate and risk margin components.
*Non-GAAP measure.
The tables below present a reconciliation of our Annualized TIR to our Annualized Adjusted TIR*:
| Three Months Ended | Nine Months Ended | |||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
| (in millions of |
||||||||||||||||
| Net investment income | $ | 116 | $ | 93 | $ | 302 | $ | 231 | ||||||||
| Net realized (losses) gains | (36 | ) | 6 | (111 | ) | 1 | ||||||||||
| Net unrealized (losses) gains | (546 | ) | (280 | ) | (1,518 | ) | 110 | |||||||||
| Earnings (losses) from equity method investments | (20 | ) | (14 | ) | 12 | 101 | ||||||||||
| TIR ($) | $ | (486 | ) | $ | (195 | ) | $ | (1,315 | ) | $ | 443 | |||||
| Non-GAAP adjustment: | ||||||||||||||||
| Net realized and unrealized losses (gains) on fixed maturity investments and funds held-directly managed | 418 | 87 | 1,161 | 183 | ||||||||||||
| Adjusted TIR ($)* | $ | (68 | ) | $ | (108 | ) | $ | (154 | ) | $ | 626 | |||||
| Total investments | $ | 14,226 | $ | 16,962 | $ | 14,226 | $ | 16,962 | ||||||||
| Cash and cash equivalents, including restricted cash and cash equivalents | 1,357 | 2,035 | 1,357 | 2,035 | ||||||||||||
| Funds held by reinsured companies | 3,727 | 2,410 | 3,727 | 2,410 | ||||||||||||
| Net variable interest entity assets | — | 448 | — | 448 | ||||||||||||
| Total investable assets | $ | 19,310 | $ | 21,855 | $ | 19,310 | $ | 21,855 | ||||||||
| Average aggregate invested assets, at fair value(1) | 20,140 | 21,889 | 20,192 | 20,737 | ||||||||||||
| Annualized TIR %(2) | (9.7 | )% | (3.6 | )% | (8.7 | )% | 2.8 | % | ||||||||
| Non-GAAP adjustment: | ||||||||||||||||
| Net unrealized losses (gains) on fixed maturities, AFS investments included within AOCI and net unrealized losses (gains) on fixed maturities, trading instruments | 1,928 | (326 | ) | 1,928 | (326 | ) | ||||||||||
| Adjusted investable assets* | $ | 21,238 | $ | 21,529 | $ | 21,238 | $ | 21,529 | ||||||||
| Adjusted average aggregate invested assets, at fair value*(3) | $ | 21,728 | $ | 21,610 | $ | 21,093 | $ | 20,411 | ||||||||
| Annualized adjusted TIR %*(4) | (1.3 | )% | (2.0 | )% | (1.0 | )% | 4.1 | % | ||||||||
(1) This amount is a two and four period average of the total investable assets for the three and nine months ended
(2) Annualized TIR % is calculated by dividing the annualized TIR ($) by average aggregate invested assets, at fair value.
(3) This amount is a two and four period average of the adjusted investable assets* for the three and nine months ended
(4) Annualized adjusted TIR %* is calculated by dividing the annualized adjusted TIR* ($) by adjusted average aggregate invested assets, at fair value*.
*Non-GAAP measure.
Contact:
Telephone: +1 (441) 292-3645
Source: Enstar Group Limited
